FDA approves first chemotherapy-free combo for CLL. SLL

AbbVie Inc. (NYSE:ABBV) and partner Johnson & Johnson (NYSE:JNJ) said FDA approved an sNDA for Imbruvica

Read the full 165 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE